Skip to main content
logo
GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
96.26
-1.90 (-1.94%)
At close: Jan 30, 2026, 4:00 PM EST
96.00
-0.26 (-0.27%)
After-hours: Jan 30, 2026, 6:50 PM EST

GeneDx Holdings Revenue

GeneDx Holdings had revenue of $116.74M in the quarter ending September 30, 2025, with 51.86% growth. This brings the company's revenue in the last twelve months to $402.19M, up 50.50% year-over-year. In the year 2024, GeneDx Holdings had annual revenue of $305.45M with 50.79% growth.

Revenue (ttm)
$402.19M
Revenue Growth
+50.50%
P/S Ratio
6.78
Revenue / Employee
$402,190
Employees
1,000
Market Cap
2.78B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020179.32M-16.85M-8.59%
Dec 31, 2019196.17M62.83M47.12%
Dec 31, 2018133.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
RadNet1.97B
Sotera Health Company1.15B
Neogen880.32M
NeoGenomics709.16M
OPKO Health642.07M
Veracyte495.14M
Twist Bioscience376.57M
CareDx358.00M
Revenue Rankings

WGS News

More News